TRESP Recruitment - Medtech and Healthtech Experts’ Post

Argentina presents a compelling proposition for #medtech #clinicaltrials, bolstered by its robust healthcare system, modern facilities, and a cadre of experienced medical professionals. Argentina's emerging prominence in the medtech sector, particularly in cosmetic and reconstructive surgeries, #regenerativemedicine, #cardiology, and other medical procedures, offers competitive expertise and pricing advantages. https://lnkd.in/eVU_KqQe #medtechsector

US FDA has authorized 882 AI-enabled medical devices via 510(k) clearance, granted De Novo request, or approved PMA in 2024, a 27% increase compared to 2023. No surprises here; Radiology has the highest number of authorizations and has the steadiest increase of AI-enabled device submissions of any specialty Radiology (671 devices): 76% Cardiovascular (90 devices): 10% Neurology (32 devices): 4% Hematology (17 devices): 2% Gastroenterology & Urology (13 devices): 1.5% each Ophthalmology (9 devices): 1% Top 5 companies are GE Healthcare - 70 devices Siemens - 64 devices Canon - 28 devices Philips - 27 devices Aidoc - 23 devices This includes company's own devices + devices from companies they have acquired. GE Healthcare acquired MIM Software (5 devices), BK Medical (2 devices), and Caption Health (5 devices). Philips acquired DiA Imaging (6 devices). Varian is now part of Siemens Healthineers (2 devices). #medicaldevices #artificialintelligence #FDA

📃Scientific paper: Accuracy of postvoid residual volumes after vaginal delivery: a prospective equivalence study to compare an automatic scanning device with transurethral catheterization Abstract: Introduction and hypothesis Abnormal postvoid residual volumes (PVRV) after delivery are common in daily clinical practice. By using an automatic scanning device, unnecessary catheterizations can be prevented. The aim of this study was to determine the accuracy of PVRV after vaginal delivery measured by an automatic scanning device through a comparison with transurethral catheterization. Materials and methods This prospective observational equivalence study was performed in patients who delivered vaginally between June 2012 and May 2017 in three teaching hospitals in The Netherlands. After the first spontaneous void after delivery, postvoid residual volume (PVRV) was measured with a portable automatic scanning device (BladderScan® BVI 9400). Directly afterward, it was measured by catheterization. Correlation between measurements was calculated using Spearman’s correlation coefficient and agreement plot. The primary outcome was to validate the correlation between the BladderScan® compared with the gold standard of transurethral catheterization. Results Data of 407 patients was used for final analysis. Median PVRV as measured by BladderScan® was 380 ml (± 261–0–999 ml) and by catheterization was 375 ml (± 315–1800 ml). Mean difference between measurements was −12.9 ml (± 178 ml). There was a very good correlation between methods (Spearman’s rho = 0.82, p  < 0.001). Using a cut-ff value of >500 ml, specificity and sensitivity were 85.4 and 85.6%, respectively. Con... Continued on ES/IODE ➡️ https://etcse.fr/hKI ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.

Looking for a research partner you can trust? Miami Clinical Research combines innovation with infrastructure to tackle any challenge in clinical trials. With services like uroscopy, endoscopy, and more, we streamline the process to help advance medical science. Want to know how we do it? Check out our latest blog: https://lnkd.in/gY8mDzaM #medicalresearch #clinicaltrials #medicalstudies #miamiclinicalresearch #pharmaceuticalresearch #clinicalstudies #biotechresearch #pharmaresearch

🤝✨ ONWARD Medical has announced a significant agreement with CEA, granting exclusive rights to Clinatec's WIMAGINE Brain-Computer Interface (BCI) technology. This partnership aims to advance innovative solutions for individuals with neurological conditions, particularly those with spinal cord injuries. The WIMAGINE technology, which translates neural signals into digital commands, offers promising potential for restoring motor function. 🧠💪 ONWARD Medical is committed to leveraging this cutting-edge BCI technology to enhance its existing neuromodulation therapies, creating a more comprehensive approach to treatment. This collaboration aligns with ONWARD Medical's mission to improve the quality of life for people with severe movement impairments. By integrating WIMAGINE's capabilities, ONWARD Medical seeks to expand its therapeutic options, ultimately enabling greater independence for patients. The agreement marks a pivotal step in ONWARD Medical's strategy to remain at the forefront of neurotechnology and showcases its dedication to innovation in the field. The combination of advanced BCI technology and ONWARD Medical's expertise positions the company to make significant strides in neurological rehabilitation. As the field of neurotechnology evolves, partnerships like this are essential for developing new therapies and enhancing patient outcomes. ONWARD Medical's collaboration with CEA not only strengthens its product offerings but also underscores its commitment to addressing unmet needs in the realm of neurorehabilitation. 🌟 Stay tuned for further updates on this exciting development and the future of BCI technology in transforming the lives of individuals facing movement challenges. https://lnkd.in/g_5ebdp2 #Neurotechnology #BCI #Innovation #Healthcare #SpinalCordInjury #MedTech #Neuromodulation

Electrophysiology Market Trends and Opportunities 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dRcaeFtn 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐞𝐥𝐞𝐜𝐭𝐫𝐨𝐩𝐡𝐲𝐬𝐢𝐨𝐥𝐨𝐠𝐲 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $8.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $15.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 13.0% 𝐟𝐫𝐨𝐦 2023 𝐭𝐨 2028. In 2022, the #northamerica region is expected to register significant growth in the market during the forecast period. North America comprises the US and Canada. North America is a center for medical technology innovation and research. New and cutting-edge electrophysiological technologies are frequently adopted early in the region, which supports market expansion. The United States, in particular, has one of the highest healthcare spending rates in the world. High healthcare spending encourages the employment of cutting-edge medical technologies, such as those utilized in electrophysiology operations. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Abbott, Medtronic., MicroPort, Johnson & Johnson #Electrophysiology #EPDevices #ArrhythmiaCare #CardiacMapping #HeartRhythm #EPProcedures #AblationTherapy #MedicalElectronics #CardiovascularHealth #InnovationsInEP

#VTAK Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a U.S. based medical device company focused on novel electrophysiology products, announced that VIVO was used for the first time on a pediatric patient in Turkey. The Company recently announced its new distribution partnership with Ege Artimi in Turkey in January. Catheter Precision's CEO, David Jenkins, said, "VIVO is an excellent choice for pre-procedure planning, especially in pediatric patients. VIVO is non-invasive and used prior to ventricular ablations, meaning that it can provide the physician with additional information specific to each patient and because it is non-invasive there is no additional risk when it is utilized. The utilization of VIVO in delicate patient populations like this continues to show the flexibility and many benefits of this innovative product." https://lnkd.in/eMNrtFrs

𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐒𝐮𝐩𝐩𝐥𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭! 🚨 📥 Download the PDF: https://lnkd.in/gyft3Cra The global Medical Supplies Market is expanding rapidly, driven by innovations across various types like Diagnostic Supplies, Dialysis Consumables, Disinfectants, Catheters, and Radiology Consumables. Key applications span across critical areas like: - Urology - Cardiology - Radiology - IVD (In Vitro Diagnostics) Top end users—Hospitals, Clinics, & Physician Offices—are fueling demand as healthcare infrastructure continues to evolve. As patient care demands rise, so does the need for efficient and reliable medical supplies. 🏥 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Medtronic, Cardinal Health, BD (US), Johnson & Johnson, Inc. (US), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Thermo Fisher Scientific, Inc. (US), Baxter (US), 3M (US), Smith+Nephew, Convatec Inc. (UK), Abbott (US), Cook Medical (US), Merit Medical Systems (US), Stryker, Terumo Medical Corporation, Teleflex Incorporated (US), Fresenius Medical Care AG & Co. KGaA (Germany), Coloplast Group (Denmark), Hamilton Medical (Switzerland), ACell, Inc. (US), Invacare Corporation (US), Medline Industries, LP. (US), DeRoyal Industries, Inc. (US), Shenzhen MedRena Biotech Co., Ltd. (China), Kerecis (US) and Whiteley (Australia) Other Companies that are Operating in this Market Globally: CCS Synapse Health Al Mazroui Medical Group Pipeline Medical Spectrum Medical Ltd GPC Medical Ltd. Better Health ASP Global AlHaya Medical Company Ltd. MXR Imaging, Inc. ABC Medical, Inc.   Triangle Medical Trading LLC AliMed TwinMed, LLC Mensa Group US MED CareGivers America MedShare Zhonghong Pulin Medical Products Preferred Homecare / Lifecare Solutions #MedicalSupplies #HealthcareInnovation #Diagnostics #Cardiology #IVD #Urology #Radiology #Hospitals #Clinics #MedicalDevices #MarketGrowth

Medtronic's Latest Innovations: Four Key Updates   Medtronic is making waves in healthcare with advancements in device technology, research, and leadership. Here’s a snapshot of the company’s recent moves:   1. FDA Approval for Affera Mapping & Ablation System: Medtronic's Affera system, newly approved by the FDA, offers a unique combination of pulsed field ablation (PFA) and radiofrequency (RF) energy for persistent atrial fibrillation (AFib) treatment. It stands out by integrating mapping technology, providing broader treatment options compared to single-mode competitors. Analysts call Affera a "meaningful upgrade," with physicians expecting it to become a go-to for many AFib cases.   2. Symplicity Spyral Renal Denervation (RDN) System’s Promising Long-Term Data: The Symplicity Spyral RDN system showed significant two-year results in lowering blood pressure through RF energy, targeting renal nerves. Outcomes from this study underscore RDN’s safety and effectiveness, with plans to expand to hepatic nerve targets for enhanced hypertension control.   3. New Competitive Edge in Electrophysiology: The Affera system could reshape the market for cardiac ablation by supporting both point-by-point RF and PFA procedures. This dual-functionality positions it strongly against major players like Abbott and Boston Scientific, enabling tailored options for more complex cardiac cases.   4. Leadership Strengthened with Dr. Matthew Kroh as CMO: Medtronic appointed Dr. Matthew Kroh as Chief Medical Officer for Advanced Surgical Technologies. With extensive expertise in minimally invasive surgery, Dr. Kroh will guide clinical strategy and foster physician collaboration, reinforcing Medtronic’s focus on patient-centred innovation.   These updates underscore Medtronic’s commitment to pioneering healthcare solutions, driving improved outcomes, and strengthening its leadership across cardiac, renal, and surgical fields.   https://lnkd.in/g6Ru-4CY https://lnkd.in/gQQKBaAh https://lnkd.in/grQxJ52i https://lnkd.in/gUWmHG-d #MedTechNews #MedicalDevices #HealthcareInnovation #MedTechIndustry #HealthTech #HealthcareTechnology #MedDeviceNews #HealthcareNews #MedTechTrends

Top 10 Medical Device Technologies Market 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞-https://lnkd.in/dc5yxzBc The global top 10 medical device technologies market in terms of revenue was estimated to be worth $437.4 billion by 2022 and is poised to reach $577.5 billion in 2027, growing at a CAGR of 5.7% from 2022 to 2027. The study categorizes the Top 10 Medical Device Technologies market to forecast revenue and analyze trends in each of the following submarkets: By In Vitro Diagnostics (IVD) Market By Cardiology Devices Market By Diagnostics Imaging Devices Market By Orthopedic Devices Market By Ophthalmology Devices Market By Endoscopy Devices Market By Diabetes Care Devices Market By Wound Car Devices Market By Kidney/Dialysis Devices Market By Respiratory Care & Anesthesia Devices Market Abbott Roche Diagnostics USA KONINKLIJKE PHILIPS ELECTRONICS NV Siemens Healthineers Stryker Boston Scientific Johnson & Johnson Medtronic Smith+Nephew GE HealthCare